Vangelista L, Laffer S, Turek R, Grönlund H, Sperr W R, Valent P, Pastore A, Valenta R
Structural Biology Programme, European Molecular Biology Laboratory, Heidelberg, Germany D-69117.
J Clin Invest. 1999 Jun;103(11):1571-8. doi: 10.1172/JCI6551.
Atopic allergy is a genetically determined immunodisorder that affects almost 20% of the population worldwide. Immediate symptoms of type I allergy are caused by the release of biologic mediators from effector cells induced by IgE-allergen complexes that cross-link the high-affinity receptor for IgE (FcepsilonRI). Chronic disease manifestations result from allergen-specific T-cell activation, a process that is enhanced when allergens are presented via FcepsilonRI-bound IgE. We report the baculovirus expression, as soluble recombinant proteins, of the minimal units required for human IgE and FcepsilonRI interaction: Cepsilon3 represents the third constant domain of the IgE heavy chain, and alpha2 is the membrane-proximal Ig-like module from FcepsilonRIalpha. Native overlay experiments showed binding of human FcepsilonRIalpha to recombinant Cepsilon3 and of natural or recombinant human IgE to recombinant alpha2. Moreover, recombinant Cepsilon3 inhibited binding of natural IgE antibodies to alpha2, and preincubation of human IgE with alpha2 inhibited anti-IgE-triggered histamine release from human basophils. Isolated Cepsilon3 and alpha2 can now be used for the molecular and structural analysis of the IgE-FcepsilonRI interaction, as well as for diagnostic and therapeutic applications.
特应性过敏是一种由基因决定的免疫紊乱疾病,全球近20%的人口受其影响。I型过敏的即时症状是由IgE-过敏原复合物诱导效应细胞释放生物介质引起的,该复合物会交联IgE的高亲和力受体(FcepsilonRI)。慢性疾病表现源于过敏原特异性T细胞活化,当过敏原通过与FcepsilonRI结合的IgE呈递时,这一过程会增强。我们报告了杆状病毒表达的人IgE与FcepsilonRI相互作用所需的最小单位,即作为可溶性重组蛋白的:Cepsilon3代表IgE重链的第三个恒定结构域,alpha2是FcepsilonRIalpha的膜近端Ig样模块。天然覆盖实验表明人FcepsilonRIalpha与重组Cepsilon3结合,天然或重组人IgE与重组alpha2结合。此外,重组Cepsilon3抑制天然IgE抗体与alpha2的结合,人IgE与alpha2预孵育可抑制抗IgE触发的人嗜碱性粒细胞组胺释放。现在,分离出的Cepsilon3和alpha2可用于IgE-FcepsilonRI相互作用的分子和结构分析,以及诊断和治疗应用。